Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System

NAActive, not recruitingINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

January 6, 2020

Study Completion Date

August 31, 2025

Conditions
Mitral Valve Regurgitation
Interventions
DEVICE

Mitral valve replacement

Transcatheter mitral valve replacement

Trial Locations (10)

10032

Columbia University Medical Center, New York

48188

Henry Ford Health System, Detroit

60611

Northwestern University, Chicago

63110

Washington University, St Louis

90048

Cedars Sinai Medical Center, Los Angeles

98195

University of Washington Medical Center, Seattle

B 2060

ZNA Middelheim, Antwerp

T6G 2B7

University of Alberta, Edmonton

V6Z 1Y6

St. Paul's Hospital, Vancouver

N6A 5A5

London Health Sciences Centre, London

All Listed Sponsors
lead

Shockwave Medical, Inc.

INDUSTRY

NCT02276547 - Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System | Biotech Hunter | Biotech Hunter